Post Profile

Calling PhRMA’s Bluff: 15 Ways To Bring US Drug Costs Under Control

Mike Magee Historically, U.S. insurers have been relatively permissive when it comes to pharmaceuticals. Most drugs were covered and reimbursed generously. That reflected two realities: drugs were a relatively small piece of the over all health care cost, and denying certain drugs coverage on formulary lists was almost always a public relations nightmare, angering both […] The post Calling PhRMA’s Bluff: 15 Ways To Bring US Drug Costs Under Control appeared first on HealthCommentary.
read more


Related Posts

Pharmacy Invoices Show Flaws in Drug Pricing Benchmarks

Medical / Pharmaceutical : Drug Channels

A new Office of Inspector General (OIG) report provides pretty compelling evidence that pharmaceutical reimbursement models need to change.  In Review of Drug Costs to Medicaid Pharmacies and Their Relation to Benchmark Prices, OIG ...

NICE VS. Not-So-NICE: A Squabble Over Reimbursement In The UK

Medical / Pharmaceutical : Pharmalot

Will drugmakers abandon the UK because the national reimbursement gatekeeper is too strict? In a recent opinion piece, Ian King, the business editor at The Times of London, warned the pharmaceutical industry will abandon drug develo...

Shire CEO: Pharma must "wake up" to new price reality - Philadelphia Business Journal

Medical / Pharmaceutical : PharmaGossip

via Shire CEO Angus Russell said Wednesday the UK-based specialty pharmaceutical company is now evaluating whether potential drugs can get reimbursed at an acceptable rate by insurers as early as Phase 1 of clinical ...

Drug Prices, Manufacturer Rebates, and the Risk to Channel Economics

Medical / Pharmaceutical : Drug Channels

Here’s a Drug Channels Zen koan for you: When does a price increase not increase the price? This riddle came to me while reviewing the excellent new Pharmaceutical Research and Manufacturers of America (PhRMA) slide deck called Pres...

The Latest in Drug Safety: PhRMA Says to Throw Unused Drugs in Household Trash

Medical / Pharmaceutical : Pharma Marketing Blog

"For the second time," reports Pharmalot (here), "the pharmaceutical industry is challenging a local government over an ordinance that requires drugmakers to cover the cost of a prescription drug ‘take back,’ or disposal program. "T...


Copyright © 2016 Regator, LLC